AbbVie Inc. (ABBV) vs Micron Technology, Inc. (MU)

AbbVie Inc. is a pharmaceutical company with significant exposure to immunology through Humira, Skyrizi, and Rinvoq, and to oncology through Imbruvica and Venclexta. The company was spun off from Abbott in early 2013. Its 2020 acquisition of Allergan expanded its portfolio with additional products in aesthetics, including Botox. In 2024, AbbVie further strengthened its business through the acquisitions of Cerevel in neuroscience and ImmunoGen in oncology.

Micron Technology is one of the world’s largest semiconductor companies, focused on memory and storage chips. Its main source of revenue comes from dynamic random access memory (DRAM), while it also maintains smaller exposure to NAND flash memory. Micron serves a global customer base, supplying chips for data centers, mobile devices, consumer electronics, as well as industrial and automotive applications. The company operates as a vertically integrated business.